Академический Документы
Профессиональный Документы
Культура Документы
NCT01933529
NCT01862029
Prediabetes NCT01521312
NCT01773707
2009-011003-23/FR
NCT01030861
NCT02005848
Type 1 DM NCT02000817
NCT02044848
NCT01947569
NCT01845064
NCT01889667
Type 2 DM
NCT01918865
NCT01970046
NCT02020616
NCT01329016
NCT01018602
Gestational
Diabetes
NCT01662921
NCT01731431
NCT01856907
NCT01822925
Diabetes-related “- NCT01928381
opathies” (need
something about NCT01863810
retinopathy)
NCT01889277
NCT01843387
NCT01994291
NCT01858597
NCT00572689
Hypoglycemia
http://clinicaltrials.gov/ct2/show/NCT01841359?term=hypoglycemia&recr=Open&cntry1=NA%3AUS&rank=5
NCT01994746 Hypoglycemia
NCT02081014 Hypoglycemia
hyperglycemia +
NCT01875107 pregnant
stress hyperglycemia
NCT01969149
Study name
ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)
Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese Individuals
A Pilot study to evaluate the Efficacy and Safety of GFT505 (80mg) orally administered once daily for 35
days in patients presenting with impaired glucose tolerance and abdominal obesity. A double blind,
parallel group, placebo-controlled and randomized study
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Phase II-III Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes
Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients
A Phase III Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes
Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of
Gestational Diabetes (INDAO)
Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent
GDM
Safety Study of DA-9801 to Treat Diabetic Neuropathy
Safety, Tolerability and Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With
PDN and Good Pain Reporting Ability
Efficacy and Safety of KW21052 Compared to Lyrica in the Diabetic Patients With Neuropathic Pain
Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy
Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy
A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor
Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
Safety and Efficacy of AKB-9778 as Monotherapy or Adjunctive to Ranibizumab Compared to
Ranibizumab Monotherapy in Subjects With Diabetic Macular Edema
another DPP-IV inhibitor (not novel), China only - I would not include
NCT01862029
NCT01521312
NCT01773707
2009-011003-23
NCT01030861
NCT02005848
NCT02000817
NCT02044848
NCT01947569
NCT01845064
NCT01889667
NCT01918865
NCT01970046
NCT02020616
NCT01329016
NCT01018602
NCT01662921
NCT01731431
NCT01856907
NCT01822925
NCT01928381
NCT01863810
NCT01889277
NCT01843387
http://clinicaltrials.gov/ct2/show/NCT01933529?term=NCT01933529&rank=1
http://clinicaltrials.gov/ct2/show/NCT01933529?term=NCT01933529&rank=1
http://clinicaltrials.gov/ct2/show/NCT01933529?term=NCT01933529&rank=1
http://clinicaltrials.gov/ct2/show/NCT01933529?term=NCT01933529&rank=1
http://clinicaltrials.gov/ct2/show/NCT01862029?term=NCT01862029&rank=1
http://clinicaltrials.gov/ct2/show/NCT01521312?term=NCT01521312&rank=1
http://clinicaltrials.gov/ct2/show/NCT01773707?term=NCT01773707&rank=1
http://clinicaltrials.gov/ct2/show/2009-011003-23?term=2009-011003-23&rank=1
http://clinicaltrials.gov/ct2/show/NCT01030861?term=NCT01030861&rank=1
http://clinicaltrials.gov/ct2/show/NCT02005848?term=NCT02005848&rank=1
http://clinicaltrials.gov/ct2/show/NCT02000817?term=NCT02000817&rank=1
http://clinicaltrials.gov/ct2/show/NCT02044848?term=NCT02044848&rank=1
http://clinicaltrials.gov/ct2/show/NCT01947569?term=NCT01947569&rank=1
http://clinicaltrials.gov/ct2/show/NCT01845064?term=NCT01845064&rank=1
http://clinicaltrials.gov/ct2/show/NCT01889667?term=NCT01889667&rank=1
http://clinicaltrials.gov/ct2/show/NCT01918865?term=NCT01918865&rank=1
http://clinicaltrials.gov/ct2/show/NCT01970046?term=NCT01970046&rank=1
http://clinicaltrials.gov/ct2/show/NCT02020616?term=NCT02020616&rank=1
http://clinicaltrials.gov/ct2/show/NCT01329016?term=NCT01329016&rank=1
http://clinicaltrials.gov/ct2/show/NCT01018602?term=NCT01018602&rank=1
http://clinicaltrials.gov/ct2/show/NCT01662921?term=NCT01662921&rank=1
http://clinicaltrials.gov/ct2/show/NCT01731431?term=NCT01731431&rank=1
http://clinicaltrials.gov/ct2/show/NCT01856907?term=NCT01856907&rank=1
http://clinicaltrials.gov/ct2/show/NCT01822925?term=NCT01822925&rank=1
http://clinicaltrials.gov/ct2/show/NCT01928381?term=NCT01928381&rank=1
http://clinicaltrials.gov/ct2/show/NCT01863810?term=NCT01863810&rank=1
http://clinicaltrials.gov/ct2/show/NCT01889277?term=NCT01889277&rank=1
http://clinicaltrials.gov/ct2/show/NCT01843387?term=NCT01843387&rank=1
CONDITION TRIAL IDENTIFIER
NCT01659385
NCT01778400
Thyroid nodules NCT00858104
NCT01750593
http://www.ncbi.nlm.nih.gov/pubmed/23780378
NCT01800617
NCT01950260
Hypothyroidism NCT01832753
EudraCT 2010-018663-42
NCT01921452
NCT01611896
NCT01269749
NCT01789541
Hyperthyroidism
NCT01295333
NCT01945229
ISRCTN62749892
NCT01837433
NCT01760421
Thyroiditis
NCT02013479
http://www.ncbi.nlm.nih.gov/pubmed/22168752
http://eanm13.eanm.org/abstracts/session_detail.php?sessionNumber=1508&referer=/progr
http://www.ncbi.nlm.nih.gov/pubmed/23616630
http://www.ncbi.nlm.nih.gov/pubmed/23782950
http://www.ncbi.nlm.nih.gov/pubmed/21591944
http://www.ncbi.nlm.nih.gov/pubmed/21563916
TABLAS) - Include?
ld be in first section?)
enign multinodular goiter